• Earnings per Share (EPS) is expected to be $0.89, a 3.5% increase from the previous year.
• Projected quarterly revenue is approximately $1.65 billion, a 35.8% rise from the previous year.
• The launch of Brown & Brown Healthcare aims to enhance market access and create competitive programs for healthcare organizations.

Brown & Brown, Inc. (NYSE: BRO) is a well-established insurance brokerage firm, founded in 1939. The company is known for offering tailored insurance solutions and has a significant global presence with over 700 locations and more than 23,000 employees. As a leader in the industry, Brown & Brown is committed to providing innovative strategies to support customer growth.

On January 26, 2026, Brown & Brown is set to release its quarterly earnings. Analysts expect the earnings per share (EPS) to be $0.89, reflecting a 3.5% increase from the same period last year. The revenue for this quarter is projected to be approximately $1.65 billion, marking a significant 35.8% rise from the previous year's quarter. This growth is indicative of the company's strong market position and effective business strategies.

Brown & Brown recently launched its National Healthcare Practice, known as Brown & Brown Healthcare. This initiative brings together over 140 specialists to offer risk and insurance solutions for healthcare organizations. The practice aims to enhance market access and create competitive programs, aligning with customer objectives. This strategic move is expected to support hundreds of clients and manage billions in premiums globally.

The company's financial metrics provide insight into its market valuation. Brown & Brown has a price-to-earnings (P/E) ratio of approximately 26.05, indicating the price investors are willing to pay for each dollar of earnings. The price-to-sales ratio is about 5.04, reflecting the value placed on its sales. Additionally, the enterprise value to sales ratio is around 6.31, suggesting the company's total valuation relative to its sales.

Brown & Brown's board of directors has declared a regular quarterly cash dividend of $0.165 per share, payable on February 11, 2026. This dividend reflects the company's commitment to returning value to its shareholders. The debt-to-equity ratio is approximately 0.64, showing a balanced approach to financing its assets. The current ratio of about 1.18 indicates the company's ability to cover short-term liabilities with its short-term assets.